MicroRNA-34a regulates the longevity-associated protein SIRT1 in coronary artery disease: Effect of statins on SIRT1 and microRNA-34a expression

Clinical Science

Volumn 123, Issue 3, 2012, Pages 161-171

  Tabuchi, Tsuyoshi ^a   Satoh, Mamoru ^a   Itoh, Tomonori ^a   Nakamura, Motoyuki ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

Atherosclerosis; Atorvastatin; Endothelial progenitor cell; Randomized prospective study; Rosuvastatin

Indexed keywords

ATORVASTATIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MICRORNA 34A; ROSUVASTATIN; SIRTUIN 1; TRIACYLGLYCEROL; FLUOROBENZENE; HEPTANOIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; MESSENGER RNA; MICRORNA; MIRN34 MICRORNA, HUMAN; PYRIMIDINE DERIVATIVE; PYRROLE DERIVATIVE; SIRT1 PROTEIN, HUMAN; SULFONAMIDE;

AGED; ARTICLE; CELL COUNT; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG EFFECT; ENDOTHELIAL PROGENITOR CELL; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE BLIND PROCEDURE; VASCULAR ENDOTHELIUM; BLOOD; CELL CULTURE; CELL MOTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; ENDOTHELIUM CELL; GENE EXPRESSION REGULATION; GENETICS; LONGEVITY; METABOLISM; OXIDATIVE STRESS; PATHOLOGY;

AGED; CELL COUNT; CELL MOVEMENT; CELLS, CULTURED; CORONARY ARTERY DISEASE; ENDOTHELIAL CELLS; FEMALE; FLUOROBENZENES; GENE EXPRESSION REGULATION; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LIPIDS; LONGEVITY; MALE; MICRORNAS; OXIDATIVE STRESS; PYRIMIDINES; PYRROLES; RNA, MESSENGER; SIRTUIN 1; SULFONAMIDES; TRANSFECTION;

EID: 84861567114     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20110563     Document Type: Article

References (44)

1. Lusis, A. J. (2000) Atherosclerosis. Nature 407, 233-241
2. Brandes, R. P., Fleming, I. and Busse, R. (2005) Endothelial aging. Cardiovasc. Res. 66, 286-294
3. Kudo, F. A., Warycha, B., Juran, P. J., Asada, H., Teso, D., Aziz, F., Frattini, J., Sumpio, B. E., Nishibe, T., Cha, C. and Dardik, A. (2005) Differential responsiveness of earlyand late-passage endothelial cells to shear stress. Am. J. Surg. 190, 763-769
4. Minamino, T. and Komuro, I. (2007) Vascular cell senescence: contribution to atherosclerosis. Circ. Res. 100, 15-26
5. Asahara, T., Murohara, T., Sullivan, A., Silver, M., van der Zee, R., Li, T., Witzenbichler, B., Schatteman, G. and Isner, J. M. (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275, 964-967
6. Shi, Q., Rafii, S., Wu, M. H., Wijelath, E. S., Yu, C., Ishida, A., Fujita, Y., Kothari, S., Mohle, R., Sauvage, L. R. et al. (1998) Evidence for circulating bone marrow-derived endothelial cells. Blood 92, 362-367
7. Satoh, M., Ishikawa, Y., Takahashi, Y., Itoh, T., Minami, Y. and Nakamura, M. (2008) Association between oxidative DNA damage and telomere shortening in circulating endothelial progenitor cells obtained from metabolic syndrome patients with coronary artery disease. Atherosclerosis 198, 347-353
8. Satoh, M., Minami, Y., Takahashi, Y., Tabuchi, T., Itoh, T. and Nakamura, M. (2009) Effect of intensive lipidlowering therapy on telomere erosion in endothelial progenitor cells obtained from patients with coronary artery disease. Clin. Sci. 116, 827-835
9. Frye, R. A. (2000) Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins. Biochem. Biophys. Res. Commun. 273, 793-798
10. Braunstein, M., Rose, A. B., Holmes, S. G., Allis, C. D. and Broach, J. R. (1993) Transcriptional silencing in yeast is associated with reduced nucleosome acetylation. Genes Dev. 7, 592-604
11. Potente, M. and Dimmeler, S. (2008) Emerging roles of SIRT1 in vascular endothelial homeostasis. Cell Cycle. 7, 2117-2122
12. Ota, H., Akishita, M., Eto, M., Iijima, K., Kaneki, M. and Ouchi, Y. (2007) Sirt1 modulates premature senescencelike phenotype in human endothelial cells. J. Mol. Cell. Cardiol. 43, 571-579
13. Bartel, D. P. (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297
14. Kim, V. N. (2005) Small RNAs: classification, biogenesis, and function. Mol. Cells 19, 1-15
15. Yamakuchi, M., Ferlito, M. and Lowenstein, C. J. (2008) miR-34a repression of SIRT1 regulates apoptosis. Proc. Natl. Acad. Sci. U.S.A. 105, 13421-13426
16. Yamakuchi, M. and Lowenstein, C. J. (2009) MiR-34, SIRT1 and p53: the feedback loop. Cell Cycle 8, 712-715
17. Saunders, L. R., Sharma, A. D., Tawney, J., Nakagawa, M., Okita, K., Yamanaka, S., Willenbring, H. and Verdin, E. (2010) miRNAs regulate SIRT1 expression during mouse embryonic stem cell differentiation and in adult mouse tissues. Aging 2, 415-431
18. Strum, J. C., Johnson, J. H., Ward, J., Xie, H., Field, J., Hester, A., Alford, A. and Waters, K. M. (2009) MicroRNA 132 regulates nutritional stress-induced chemokine production through repression of SirT1. Mol. Endocrinol. 23, 1876-1884
19. Zhu, H., Yang, Y., Wang, Y., Li, J., Schiller, P. W. and Peng, T. (2011) MicroRNA-195 promotes palmitate-induced apoptosis in cardiomyocytes by down-regulating Sirt1. Cardiovasc. Res. 92, 75-84
20. Rane, S., He, M., Sayed, D., Vashistha, H., Malhotra, A., Sadoshima, J., Vatner, D. E., Vatner, S. F. and Abdellatif, M. (2009) Down-regulation of miR-199a derepresses hypoxia-inducible factor-1α and Sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes. Circ. Res. 104, 879-886
21. Strandberg, T. E., Vanhanen, H. and Tikkanen, M. J. (1999) Effect of statins on C-reactive protein in patients with coronary artery disease. Lancet 353, 118-119
22. Sacks, F. M., Pfeffer, MA., Moye, LA., Rouleau, J. L., Rutherford, J. D., Cole, T. G., Brown, L., Warnica, J.W., Arnold, J. M., Wun, C. C. et al. (1996) The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and recurrent events trial investigators. N. Engl. J. Med. 335, 1001-1009
23. Ota, H., Eto, M., Kano, M. R., Kahyo, T., Setou, M., Ogawa, S., Iijima, K., Akishita, M. and Ouchi, Y. (2010) Induction of endothelial nitric oxide synthase, SIRT1, and catalase by statins inhibits endothelial senescence through the Akt pathway. Arterioscler., Thromb., Vasc. Biol. 30, 2205-2211
24. Prater, D. N., Case, J., Ingram, D. A. and Yoder, M. C. (2007)Working hypothesis to redefine endothelial progenitor cells. Leukemia 21, 1141-1149
25. -ΔΔCT method. Methods 25, 402-408
26. Friedewald, W. T., Levy, R. I. and Fredrickson, D. S. (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18, 499-502
27. Ross, R. (1999) Atherosclerosis: an inflammatory disease. N. Engl. J. Med. 340, 115-126
28. Hill, J. M., Zalos, G., Halcox, J. P., Schenke, W. H., Waclawiw, M. A., Quyyumi, A. A. and Finkel, T. (2003) Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N. Engl. J. Med. 348, 593-600
29. Csiszar, A., Labinskyy, N., Jimenez, R., Pinto, JT., Ballabh, P., Losonczy, G., Pearson, KJ., de Cabo, R. and Ungvari, Z. (2009) Anti-oxidative and anti-inflammatory vasoprotective effects of caloric restriction in aging: role of circulating factors and SIRT1. Mech. Ageing Dev. 130, 518-527
30. Yang, J., Wang, N., Zhu, Y. and Feng, P. (2011) Roles of SIRT1 in high glucose-induced endothelial impairment: association with diabetic atherosclerosis. Arch. Med. Res. 42, 354-360
31. Mattagajasingh, I., Kim, C. S., Naqvi, A., Yamamori, T., Hoffman, T. A., Jung, S. B., DeRicco, J., Kasuno, K. and Irani, K. (2007) SIRT1 promotes endothelium-dependent vascular relaxation by activating endothelial nitric oxide synthase. Proc. Natl. Acad. Sci. U.S.A. 104, 14855-14860
32. Lemarié, C. A., Shbat, L., Marchesi, C., Angulo, O. J., Deschênes, M. E., Blostein, M. D., Paradis, P. and Schiffrin, E. L. (2011) Mthfr deficiency induces endothelial progenitor cell senescence via uncoupling of eNOS and down-regulation of SIRT1. Am. J. Physiol. Heart Circ. Physiol. 300, H745-H753
33. Zhao, T., Li, J. and Chen, A. F. (2010) MicroRNA-34a induces endothelial progenitor cell senescence and impedes its angiogenesis via suppressing silent information regulator 1. Am. J. Physiol. Endocrinol. Metab. 299, E110-E116
34. Kuehbacher, A., Urbich, C., Zeiher, A. M. and Dimmeler, S. (2007) Role of Dicer and Drosha for endothelial microRNA expression and angiogenesis. Circ. Res. 101, 59-68
35. Suarez, Y. and Sessa, W. C. (2009) MicroRNAs as novel regulators of angiogenesis. Circ. Res. 104, 442-454
36. Urbich, C., Kuehbacher, A. and Dimmeler, S. (2008) Role of microRNAs in vascular diseases, inflammation, and angiogenesis. Cardiovasc. Res. 79, 581-588
37. He, L., He, X., Lim, L. P., de Stanchina, E., Xuan, Z., Liang, Y., Xue, W., Zender, L., Magnus, J., Ridzon, D. et al. (2007) A microRNA component of the p53 tumour suppressor network. Nature 447, 1130-1134
38. Hermeking, H. (2007) p53 enters the microRNA world. Cancer Cell. 12, 414-418
39. Zhang, Q., Kandic, I. and Kutryk, M. J. (2011) Dysregulation of angiogenesis-related microRNAs in endothelial progenitor cells from patients with coronary artery disease. Biochem. Biophys. Res. Commun. 405, 42-46
40. Mason, R. P., Walter, M. F., Day, C. A. and Jacob, R. F. (2006) Active metabolite of atorvastatin inhibits membrane cholesterol domain formation by an antioxidant mechanism. J. Biol. Chem. 281, 9337-9345
41. Schmidt-Lucke, C., Fichtlscherer, S., Rössig, L., Kämper, U. and Dimmeler, S. (2010) Improvement of endothelial damage and regeneration indexes in patients with coronary artery disease after 4 weeks of statin therapy. Atherosclerosis 211, 249-254
42. Minami, Y., Satoh, M., Maesawa, C., Takahashi, Y., Tabuchi, T., Itoh, T. and Nakamura, M. (2009) Effect of atorvastatin on microRNA 221/222 expression in endothelial progenitor cells obtained from patients with coronary artery disease. Eur. J. Clin. Invest. 39, 359-367
43. Tousoulis, D., Andreou, I., Tsiatas, M., Miliou, A., Tentolouris, C., Siasos, G., Papageorgiou, N., Papadimitriou, C. A., Dimopoulos, M. A. and Stefanadis, C. (2011) Effects of rosuvastatin and allopurinol on circulating endothelial progenitor cells in patients with congestive heart failure: the impact of inflammatory process and oxidative stress. Atherosclerosis 214, 151-157
44. Smith, Jr, S. C., Allen, J., Blair, S. N., Bonow, R. O., Brass, L. M., Fonarow, G. C., Grundy, S. M., Hiratzka, L., Jones, D., Krumholz, H. M. et al. (2006) AHA/ACC; National Heart, Lung, and Blood Institute: AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation 113, 2363-2372